Home Details
| Official Symbol of Gene | Tlr2 |
| Species | Mus musculus |
| Entrez Gene ID | 24088 |
| Official Full Name | toll-like receptor 2 |
| Also known as | Ly105 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSMUSG00000027995 AllianceGenome:MGI:1346060 |
| Map Location | 3; 3 E3 |
| Drug | Toll-like receptor 2 and 4 antagonism |
| Interaction Type | inhibitor |
| Descent | C57BL/6J |
| Disease | experimental autoimmune encephalomyelitis |
| Pubmed ID | 33358978 |
| Year | 2022 |
| Title | Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain |
| Result | The data demonstrated that blocking TLR2/TLR4 suppressed EAE-related pain, equally in males and females; upregulation of dorsal spinal cord proinflammatory gene expression for TLR2, TLR4, NLRP3, interleukin-1β, IkBα, TNF-α and interleukin-17; and upregulation of dorsal spinal cord expression of glial immunoreactivity markers. |
| Mechanism/pathway | Toll-like receptors 2 and 4 (TLR2/TLR4) have emerged as targets for treating a wide array of autoimmune disorders, including MS, as well as having demonstrated success at suppressing pain in diverse animal models. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.